Our results highlight MET and VEGFR2 as important targets in PCa metastases, especially in bone, as levels of MET, P-MET and VEGFR2 were significantly upregulated in PCa BM as compared to primary PCa. The gene discussed is KDR; the disease is posterior cortical atrophy.